Table 5.
Resolutions of comorbidities and revision surgery for different BP-limb lengths
| Variables | 150 | 180 | 200 | P-value |
|---|---|---|---|---|
| N = 632 | N = 172 | N = 388 | N = 72 | |
| Hypertension (preoperative) | 58 (34%) | 130 (34%) | 21 (29%) | 0.76 |
| Remission hypertension | ||||
| Total | 28 (49%) | 69 (53%) | 10 (48%) | 0.83 |
| Partial | 24 (42%) | 47 (36%) | 11 (52%) | 0.33 |
| None | 5 (9%) | 14 (11%) | 0 (0%) | 0.28 |
| T2D (preoperative) | 31 (18%) | 80 (21%) | 15 (21%) | 0.76 |
| Remission T2D | ||||
| Total | 21 (68%) | 59 (76%) | 13 (87%) | 0.37 |
| Partial | 10 (32%) | 19 (24%) | 2 (13%) | 0.37 |
| Conversion to RYGB | 22 (13%) | 38 (10%) | 9 (13%) | 0.52 |
| Revision BP-limb | 2 (1%) | 1 (0.3%) | 0 (0%) | 0.29 |
| Undo | 1 (1%) | 0 (0%) | 0 (0%) | 0.25 |
| Suboptimal weight loss at one year follow-up | ||||
| %EWL < 50 | 4 (2%) | 26 (7%) | 6 (8%) | 0.08 |
Values are number (%) of subjects
T2D, diabetes mellitus type 2; RYGB, Roux-en-Y gastric bypass; BP, biliopancreatic; BMI, body mass index; EWL, excess weight loss